These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 12657823

  • 21. Pre-existing YMDD mutants in treatment-naïve patients with chronic hepatitis B are not selected during lamivudine therapy.
    Lee SH, Kim HS, Byun IS, Jeong SW, Kim SG, Jang JY, Kim YS, Kim BS.
    J Med Virol; 2012 Feb; 84(2):217-22. PubMed ID: 22170540
    [Abstract] [Full Text] [Related]

  • 22. Association of core promoter mutations with viral breakthrough in chronic hepatitis B patients on long-term lamivudine therapy.
    Kazim SN, Chauhan R, Das BC, Sarin SK.
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1525-32. PubMed ID: 16928212
    [Abstract] [Full Text] [Related]

  • 23. Genotypic and phenotypic resistance: longitudinal and sequential analysis of hepatitis B virus polymerase mutations in patients with lamivudine resistance after liver transplantation.
    Ben-Ari Z, Daudi N, Klein A, Sulkes J, Papo O, Mor E, Samra Z, Gadba R, Shouval D, Tur-Kaspa R.
    Am J Gastroenterol; 2003 Jan; 98(1):151-9. PubMed ID: 12526951
    [Abstract] [Full Text] [Related]

  • 24. [A real-time PCR assay for the quantification of hepatitis B virus DNA and concurrent detection of YMDD motif mutations].
    Ağca H, Sayıner AA, Sengönül A, Simşek I, Akarsu M.
    Mikrobiyol Bul; 2011 Oct; 45(4):664-76. PubMed ID: 22090297
    [Abstract] [Full Text] [Related]

  • 25. Comparison of mass spectrometric analysis and TRUGENE HBV genotyping for monitoring lamivudine resistance in chronic hepatitis B patients.
    Woo HY, Park H, Kim BI, Jeon WK, Cho YK, Kim YJ.
    Antivir Ther; 2007 Oct; 12(1):7-13. PubMed ID: 17503742
    [Abstract] [Full Text] [Related]

  • 26. Hepatitis B virus quantification and detection of YMDD mutants in a single reaction by real-time PCR and annealing curve analysis.
    Shih YH, Yeh SH, Chen PJ, Chou WP, Wang HY, Liu CJ, Lu SF, Chen DS.
    Antivir Ther; 2008 Oct; 13(4):469-80. PubMed ID: 18672526
    [Abstract] [Full Text] [Related]

  • 27. [Dynamic variations of hepatitis B virus polymerase gene in lamivudine-treated hepatitis B patients].
    Feng B, Wei L, Chen M, Han FZ, Wang LP.
    Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):327-30. PubMed ID: 16732904
    [Abstract] [Full Text] [Related]

  • 28. PCR restriction fragment length polymorphism in detection of YMDD variants of viral polymerase in hepatitis B virus patients treated with lamivudine.
    Yang DH, Liang WF, Xie YJ, Zhao NF, Fan J.
    Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):232-7. PubMed ID: 14612274
    [Abstract] [Full Text] [Related]

  • 29. Mutational patterns of hepatitis B virus genome and clinical outcomes after emergence of drug-resistant variants during lamivudine therapy: analyses of the polymerase gene and full-length sequences.
    Enomoto M, Tamori A, Kohmoto MT, Morikawa H, Habu D, Sakaguchi H, Takeda T, Seki S, Kawada N, Shiomi S, Nishiguchi S.
    J Med Virol; 2007 Nov; 79(11):1664-70. PubMed ID: 17854034
    [Abstract] [Full Text] [Related]

  • 30. [Detection and identification of emergence of HBV YMDD motif mutation during lamivudine treatment by hybridization to an oligonucleotide array].
    Zhao W, Liu W, Liu QJ, Zhang L, Zhang HR, Liu XJ, Zhou ZX.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Dec; 17(4):339-43. PubMed ID: 15340547
    [Abstract] [Full Text] [Related]

  • 31. [Clinical and virologic characteristics of lamivudine resistance in HBV-associated chronic liver disease].
    Kim SS, Chung MG, Ju KT, Park DK, Kwon OS, Koo YS, Kim YK, Choi DJ, Hwang YJ, Kim JH.
    Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):405-17. PubMed ID: 12506245
    [Abstract] [Full Text] [Related]

  • 32. [Relationship between hepatitis B virus YMDD mutation and serum viral DNA loadings].
    Kong LH, Gao SX, Gui YP, Liu WH.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1262-3. PubMed ID: 17715043
    [Abstract] [Full Text] [Related]

  • 33. Detection of YMDD motif mutants by oligonucleotide chips in lamivudine-untreated patients with chronic hepatitis B virus infection.
    Heo J, Cho M, Kim HH, Shin YM, Jang HJ, Park HK, Kim CM, Kim GH, Kang DH, Song GA, Yang US.
    J Korean Med Sci; 2004 Aug; 19(4):541-6. PubMed ID: 15308845
    [Abstract] [Full Text] [Related]

  • 34. Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients.
    Selabe SG, Lukhwareni A, Song E, Leeuw YG, Burnett RJ, Mphahlele MJ.
    J Med Virol; 2007 Nov; 79(11):1650-4. PubMed ID: 17854040
    [Abstract] [Full Text] [Related]

  • 35. Outcome of lamivudine resistant hepatitis B virus mutant post-liver transplantation on lamivudine monoprophylaxis.
    Chan HL, Chui AK, Lau WY, Chan FK, Hui AY, Rao AR, Wong J, Lai EC, Sung JJ.
    Clin Transplant; 2004 Jun; 18(3):295-300. PubMed ID: 15142051
    [Abstract] [Full Text] [Related]

  • 36. Long-term follow-up of chronic hepatitis B after the emergence of mutations in the hepatitis B virus polymerase region.
    Natsuizaka M, Hige S, Ono Y, Ogawa K, Nakanishi M, Chuma M, Yoshida S, Asaka M.
    J Viral Hepat; 2005 Mar; 12(2):154-9. PubMed ID: 15720530
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Detection of hepatitis B virus polymerase variations resistant to lamivudine therapy.
    Zhang X, Han Y, Lu Z, Zhang D, Cai Y.
    Chin Med J (Engl); 2000 May; 113(5):455-7. PubMed ID: 11776105
    [Abstract] [Full Text] [Related]

  • 39. Application of PCR-LDR-nucleic acid detection strip in detection of YMDD mutation in hepatitis B patients treated with lamivudine.
    Xu G, You Q, Pickerill S, Zhong H, Wang H, Shi J, Luo Y, You P, Kong H, Lu F, Hu L.
    J Med Virol; 2010 Jul; 82(7):1143-9. PubMed ID: 20513076
    [Abstract] [Full Text] [Related]

  • 40. Clinical and virological characteristics of lamivudine resistance in chronic hepatitis B patients: a single center experience.
    Sun J, Wang Z, Ma S, Zeng G, Zhou Z, Luo K, Hou J.
    J Med Virol; 2005 Mar; 75(3):391-8. PubMed ID: 15648063
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.